IDT Biologika’s Response to the COVID-19 Pandemic

Dear Partners & Colleagues,

In the face of the uncertainties of COVID-19, we want to assure you that we are taking our responsibility seriously. We are making every effort to protect our employees and to ensure the delivery of the vital vaccines and biologics of our clients for the health of people worldwide.

Regarding the availability and health of our employees, we are committed to our pandemic preparedness plan. The well-being of our employees and customers is our primary concern. IDT Biologika employees are following the recommendations from local authorities and respect safety measures as instructed.

All staff that are able to work from a remote location are doing so with meetings being held virtually.

To assure business continuity and maintenance of our development and manufacturing schedules we closely follow up on our supply chain. Our priority is to focus our available resources on the management of operations.